Form 4: Boston Scientific EVP and CFO Daniel J. Brennan Reports Transactions in Company Stock

Sentiment:

SEC Form 4 Filing


Daniel J. Brennan, EVP and CFO of Boston Scientific, reports the acquisition and disposal of company stock and derivative securities.

Summary

  • Daniel J. Brennan, the EVP and CFO of Boston Scientific, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
  • The transactions include the acquisition of common stock through the vesting of restricted stock units and stock options.
  • Brennan also disposed of common stock to cover tax obligations related to the vesting of these units.
  • The reported transactions occurred between February 13, 2025, and February 17, 2025.
  • Following these transactions, Brennan directly owns 250,148 shares of Boston Scientific common stock.
  • He also holds 8,950 restricted stock units granted on February 13, 2025, vesting in equal annual installments beginning February 13, 2026.
  • Additionally, Brennan holds options to purchase 23,031 shares of common stock, granted on February 13, 2025, vesting in equal annual installments beginning February 13, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There is no indication of unusual or concerning activity.

Positives

  • The acquisition of shares through vesting of restricted stock units and stock options can be seen as a positive sign, indicating management's alignment with the company's long-term success.
  • The grant of new restricted stock units and stock options further incentivizes the executive to perform well.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

  • Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock units.
  • The vesting schedules for stock options and restricted stock units are typically structured to incentivize long-term performance and retention.
  • The disposal of shares to cover tax obligations is a common practice among executives who receive equity compensation.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • The filing provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

DateDescription
02/13/2025Date of grant of restricted stock units and stock options.
02/13/2026First anniversary of the date of grant for restricted stock units and stock options, marking the beginning of the vesting period.
02/14/2025Transaction date for acquisition and disposal of common stock.
02/16/2025Transaction date for acquisition and disposal of common stock.
02/17/2025Transaction date for acquisition and disposal of common stock.
02/18/2025Date of signature for the Form 4 filing.
02/13/2029Expiration date for restricted stock units granted on 02/13/2025.
02/13/2035Expiration date for stock options granted on 02/13/2025.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.